1. Home
  2. RR vs LRMR Comparison

RR vs LRMR Comparison

Compare RR & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

HOLD

Current Price

$1.92

Market Cap

483.0M

Sector

N/A

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$5.04

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RR
LRMR
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
483.0M
455.8M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
RR
LRMR
Price
$1.92
$5.04
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$4.00
$16.50
AVG Volume (30 Days)
6.7M
2.0M
Earning Date
05-13-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,045,000.00
N/A
Revenue This Year
$75.68
N/A
Revenue Next Year
$78.28
$1,816.14
P/E Ratio
N/A
N/A
Revenue Growth
18.99
N/A
52 Week Low
$1.69
$1.61
52 Week High
$7.43
$6.42

Technical Indicators

Market Signals
Indicator
RR
LRMR
Relative Strength Index (RSI) 34.57 57.68
Support Level $1.81 $3.14
Resistance Level $2.04 $5.37
Average True Range (ATR) 0.14 0.31
MACD 0.02 0.00
Stochastic Oscillator 11.00 87.96

Price Performance

Historical Comparison
RR
LRMR

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: